GORDON CONFERENCE ON CANCER CHEMOTHERAPY

描述：戈登化疗会议旨在促进 基础科学家之间的讨论、合作和进展， 临床水平感兴趣的化学治疗管理的癌症。 除了审查有关当前的最新信息和想法外， 癌症化疗的研究领域，尽一切努力集中在 讨论肿瘤生物学中可能产生新的 治疗目标 总的主题将是确定 以及开发具有潜在的抗癌药物， 对恶性细胞、生物化学和分子生物学都有真正的选择性， 克服耐药性的策略。 1994年的主题 戈登会议将包括细胞周期控制的作用， 对化疗的反应，药物设计和发现的新方法， 抗癌化疗药物抗性的生化调节 药物，突出在化疗药物反应中的作用， 逆转对氯乙基化剂和公认的药物的耐药性 通过MDR转运蛋白P-糖蛋白，新的方法来了解 细胞药理学和贩毒，以及分子技术， 参与恶性肿瘤、耐药性和 药物敏感性

Description: The Gordon Conference on Chemotherapy is designed to promote discussion, collaboration, and progress among scientists at the basic and clinical levels interested in the chemotherapeutic management of cancer. In addition to reviewing the latest information and ideas about current areas of research in cancer chemotherapy, every effort is made to focus discussions on emerging topics in tumor biology that may yield new therapeutic targets. The overall theme will be on the identification and development of anticancer agents that have the potential of being truly selective for malignant cells, and for biochemical and molecular strategies for overcoming drug resistance. The subjects of the 1994 Gordon Conference will include the role of cell cycle control in the response to chemotherapy, novel approaches to drug design and discovery, biochemical modulation of drug resistance to anti-cancer chemotherapeutic agents, the role of a proptosis in chemotherapeutic drug response, reversal of resistance to chloroethylating agents and agents recognized by the MDR transporter p-glycoprotein, new approaches to understanding cellular pharmacology and drug trafficking, and molecular techniques for the identification of genes involved in malignancy, drug resistance and drug sensitivity.